{"disease":{"id":"pd-1-inhibitors","name":"pd 1 inhibitors"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06631326","title":"HAIC in Combination With PD-1 Inhibitors and Lenvatinib for High Tumor Burden Advanced HCC (CHANCE2416)","phase":"","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"First Hospital of China Medical University","has_results":false},{"nct_id":"NCT07239661","title":"Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Kong Fanming","has_results":false},{"nct_id":"NCT07086300","title":"Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Kong Fanming","has_results":false},{"nct_id":"NCT05549336","title":"Single-center, Prospective Cohort Study of PD-1 Inhibitors on Clinical Outcomes of Carotid Plaques in Tumor Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT05498805","title":"PD-1 Inhibitors With or Without Radiation in Advanced Melanoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":92,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT07359040","title":"Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":80,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT04611711","title":"Phase I/II Clinical Study of Decitabine Combined With TQB2450 Injection or Decitabine + Anlotinib Combined With TQB2450 Injection in the Treatment of PD-1 Monoclonal Antibody-resistant Digestive System Tumors","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT05520814","title":"PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Sichuan Cancer Hospital and Research Institute","has_results":false},{"nct_id":"NCT06708650","title":"Combination of SFRT, PD-L1 Inhibitor, and Anti-VEGF in Advanced Hepatocellular Carcinoma","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"Guiping People's Hospital","has_results":false},{"nct_id":"NCT04490421","title":"Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"Fuzhou General Hospital","has_results":false},{"nct_id":"NCT07067385","title":"Personalized mRNA Cancer Vaccine for Gastrointestinal Solid Tumor Treatment","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT06195254","title":"Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"Peking University Third Hospital","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}